Mark-Andre Freyberg Insider Profile
4 Followers
Mark-Andre Freyberg, Chief Executive Officer at CytoTools AG, holds ― shares in CytoTools AG (Ticker: DE:T5O). Most recently, Mark-Andre Freyberg Bought 2,000 shares of CytoTools AG on Aug 27, 2020 for an estimated value of €23.25K.
Mark-Andre Freyberg's Trading History
| T5OCytoTools AG | Aug 27, 2020 | Chief Executive Officer | Informative Buy | 23.25K | ― | |||||||||||||||||||||||||||||||||||||||||||
DE:T5O
| ||||||||||||||||||||||||||||||||||||||||||||||||
You May Also Like
Mark-Andre Freyberg insider profile FAQ
What is the percentage of profitable transactions made by Mark-Andre Freyberg?
The percentage of profitable transactions made by Mark-Andre Freyberg is 25%.
What is the average return per transaction made by Mark-Andre Freyberg?
The average return per transaction made by Mark-Andre Freyberg is -6.40%.
What stocks does Mark-Andre Freyberg hold?
Mark-Andre Freyberg holds: DE:T5O stocks.
What was Mark-Andre Freyberg’s latest transaction?
Mark-Andre Freyberg’s latest transaction was an Informative Buy of €23.25K.
What was Mark-Andre Freyberg's most profitable transaction?
Mark-Andre Freyberg’s most profitable transaction was an Informative Buy of DE:T5O stock on January 3, 2020. The return on the trade was 19.70%.
What is Mark-Andre Freyberg's role in CytoTools AG?
Mark-Andre Freyberg's role in CytoTools AG is Chief Executive Officer.
How can I follow the stock ratings of top corporate insiders?
Head over to our Expert Center to see a list of the Top 100 corporate insiders and follow the corporate insiders of your choice. Visit their profiles for more details about their stock transactions and see how they perform on a stock-by-stock basis.
TipRanks measures corporate insiders by the stock transactions they report to the SEC. See how TipRanks ranks experts and calculates performance.
